BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9102164)

  • 21. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging.
    Yamamoto K; Shimokawa T; Yi H; Isobe K; Kojima T; Loskutoff DJ; Saito H
    Am J Pathol; 2002 Nov; 161(5):1805-14. PubMed ID: 12414527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells: their possible mechanism of action.
    Soeda S; Fujii N; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1995 Oct; 1269(1):85-90. PubMed ID: 7578276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
    Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
    Shatos MA; Doherty JM; Penar PL; Sobel BE
    Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-κB p65 Knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cells type II.
    Liu B; Wu Y; Wang Y; Cheng Y; Yao L; Liu Y; Qian H; Yang H; Shen F
    Exp Lung Res; 2018; 44(4-5):241-251. PubMed ID: 30449218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells.
    Li X; Kimura H; Hirota K; Kasuno K; Torii K; Okada T; Kurooka H; Yokota Y; Yoshida H
    Kidney Int; 2005 Aug; 68(2):569-83. PubMed ID: 16014034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells.
    Maruyama K; Morishita E; Yuno T; Sekiya A; Asakura H; Ohtake S; Yachie A
    Thromb Res; 2012 Sep; 130(3):e188-93. PubMed ID: 22819264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of rivaroxaban on the injury during endotoxin-induced damage to human umbilical vein endothelial cells].
    Shi M; Huang J; Sun X; Wang F; Chu X; Jiang R; Wang Y; Pang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):468-473. PubMed ID: 31109423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of lipoxin A(4) on lipopolysaccharide-induced endothelial hyperpermeability in human umbilical vein endothelial cell].
    Pang HY; Huang YP; Liu ZJ; Yi P; Gong JM; Hao H; Wu P; Zhou J; Cai L; Huang YJ; Ye DY; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):199-204. PubMed ID: 21575454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The anti-inflammatory effects of idazoxan on inflammatory mediator release in endotoxin-challenged mice in vivo and activated macrophages in vitro].
    Li X; Zhu J; Ma W; Luo L; Liang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):445-9. PubMed ID: 29920042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells.
    Huang TH; Tran VH; Roufogalis BD; Li Y
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):30-6. PubMed ID: 17141290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of calcium ionophore A23187 on tissue factor activity and mRNA in endothelial cells.
    Wakita K; Stearns-Kurosawa DJ; Marumoto Y
    Thromb Res; 1994 Apr; 74(2):95-103. PubMed ID: 8029820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.
    Samad F; Yamamoto K; Loskutoff DJ
    J Clin Invest; 1996 Jan; 97(1):37-46. PubMed ID: 8550848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
    Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
    Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anisodamine inhibits endotoxin-induced tissue factor expression in human endothelial cells.
    Ruan Q; Song J; Deng Z
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):273-5, 278. PubMed ID: 12674755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.